nrzxfquxq
95%
Dołączył: 13 Gru 2010
Posty: 557
Przeczytał: 0 tematów
Ostrzeżeń: 0/5
Skąd: England
|
| Temat postu: Bcl-2 protein, Ki-67 antigen, estrogen receptor an |
|
|
Bcl-2 protein, Ki-67 antigen, estrogen receptor and progesterone receptor in adenomyosis endometrial carcinoma
, Eta1. Uterinearteryembolizafionforadenomyosiswithoutfibroids. ClinRadiol. 2004,[link widoczny dla zalogowanych],59:520-526.2 EzakiK, MotoyamaH, SasakiH. Immunohistologiclocalizationofestronesulfataseinuterineendometriumandadenomyosis. ObstetGynecol ,[link widoczny dla zalogowanych],2001,98:815-819 .3 GhobrialIM, WitzigTE, AdjeiAA. Targetingapoptosispathwaysincancertherapy. CAcancerJClin ,2005,55:178-194 .4 Qinx, ShigekiT, NoriyukiO, eta1. ProgesteronereceptormodulatorCDB ·-2914down · · regulatesproliferativecellnuclearantigenandbcl - 2proteinexpressionandup · regulatescaspase a 3andpoly (Adenosine5 a diphosphate-ribose) polymeraseexpressioninculturedhumanuterineleiomyomacells. JClinEndocrinolMetab ,2005,[link widoczny dla zalogowanych],90:953-961 .5 MaiaHJ, MaltezA, StudartE, eta1. Effectofmenstrualcycleandhormonaltreatmentonki-67andbcl · 2expressionandadenomyosis. GynecolEndocrinol ,2005,20:127-131 .6 MaiaHJ, MaltezA, StudartE, eta1. Proliferationkineticsinadeno-myosisduringtheme ~ tmalcycleandduringoralcontraceptiveuse. GynecolEndocrinol,[link widoczny dla zalogowanych], 2004, l8: l0l a 106.7NasuK, NishidaM, UedaT, eta1. Applicationofthenuclearfactor-kappaBinhibitor, BAY11-7085, forthetreatmentofendometriosis: aninvitrostudy. AmJPhysiolEndocrinolMetab, 2OO6 ,8:771-776 .8 NishidaM, NasuK, UedaT, eta1. B · HydroxyisovalerylshikonininducesapoptosisandG0/GIcell · cyclearrestofendometrioticstromalcells: apreliminaryinvitrostudy. HumReprod ,2006,6:283-288 .9 NasuK, NishidaM, UedaT,[link widoczny dla zalogowanych], eta1. BufalininducesapoptosisandtheG0/GIcellcyclearrestofendometrioticstromalcells: apromisingagentforthetreatmentofendometriosis. MolHumReprod, 2005,11:8 l723.
Post został pochwalony 0 razy
|
|
Nasz button 
Autor
